Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-012409
Filing Date
2021-05-17
Accepted
2021-05-17 09:20:28
Documents
39
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rvph20210331_10q.htm 10-Q 358059
2 EXHIBIT 31.1 ex_249636.htm EX-31.1 9156
3 EXHIBIT 31.2 ex_249637.htm EX-31.2 9167
4 EXHIBIT 32.1 ex_249638.htm EX-32.1 6942
  Complete submission text file 0001437749-21-012409.txt   1886013

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rvph-20210331.xml EX-101.INS 209299
6 XBRL TAXONOMY EXTENSION SCHEMA rvph-20210331.xsd EX-101.SCH 27245
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvph-20210331_cal.xml EX-101.CAL 17167
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20210331_def.xml EX-101.DEF 185994
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20210331_lab.xml EX-101.LAB 160497
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20210331_pre.xml EX-101.PRE 197381
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38634 | Film No.: 21928001
SIC: 2834 Pharmaceutical Preparations